How to buy Geron Corporation stock (GERN)

Geron Corporation is a biotechnology business based in the US. Geron Corporation shares (GERN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.66 – a decrease of 5.18% over the previous week. Geron Corporation employs 141 staff and has a trailing 12-month revenue of around $29.5 million.

Our top picks for where to buy Geron Corporation stock

Buy Geron Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Geron Corporation stock price (NASDAQ: GERN)

Use our graph to track the performance of GERN stocks over time.

Geron Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$3.66
52-week range	$1.64 - $5.34
50-day moving average more info button	$4.06
200-day moving average more info button	$4.05
Wall St. target price	$7.61
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.32

Is it a good time to buy Geron Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Geron Corporation price performance over time

Historical closes compared with the close of $3.77 from 2024-12-18

1 week (2024-12-13)	-2.33%
1 month (2024-11-21)	-6.22%
3 months (2024-09-20)	-19.96%
6 months (2024-06-20)	-15.47%

1 year (2023-12-20)	74.54%
2 years (2022-12-20)	84.80%
3 years (2021-12-20)	181.34%
5 years (2019-12-20)	161.81%

Geron Corporation financials

Revenue TTM	$29.5 million
Gross profit TTM	$-93,668,000
Return on assets TTM	-30.3%
Return on equity TTM	-69.03%
Profit margin	0%
Book value	$0.49
Market Capitalization more info button	$2.3 billion

TTM: trailing 12 months

Geron Corporation share dividends

We're not expecting Geron Corporation to pay a dividend over the next 12 months.

Have Geron Corporation's shares ever split?

Geron Corporation's shares were split on a 1058:1000 basis on 21 July 2014 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1058 shares. This wouldn't directly have changed the overall worth of your Geron Corporation shares – just the quantity. However, indirectly, the new 5.5% lower share price could have impacted the market appetite for Geron Corporation shares which in turn could have impacted Geron Corporation's share price.

Geron Corporation share price volatility

Over the last 12 months, Geron Corporation's shares have ranged in value from as little as $1.64 up to $5.34. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Geron Corporation's is 0.515. This would suggest that Geron Corporation's shares are less volatile than average (for this exchange).

Geron Corporation overview

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California. .

Frequently asked questions

null
What percentage of Geron Corporation is owned by insiders or institutions?
Currently 0.086% of Geron Corporation shares are held by insiders and 85.384% by institutions. How many people work for Geron Corporation?
Latest data suggests 141 work at Geron Corporation. When does the fiscal year end for Geron Corporation?
Geron Corporation's fiscal year ends in December. Where is Geron Corporation based?
Geron Corporation's address is: 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404 What is Geron Corporation's ISIN number?
Geron Corporation's international securities identification number is: US3741631036 What is Geron Corporation's CUSIP number?
Geron Corporation's Committee on Uniform Securities Identification Procedures number is: 374163103